The Latest Breaking News from Weight Loss

Oprah Winfrey has spoken openly about using GLP-1s to lose weight in the last few years

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.

Twelve percent of Americans reportedly take a GLP-1, according to a recent poll

When Matt Damon recently credited his weight loss to going gluten-free, it reignited a familiar debate about this divisive dietary approach. But while The Odyssey star’s claims have sparked discussion, the science behind weight loss tells a far more nuanced story than simply cutting out a single protein.

Sudden appetite loss can signal infections, chronic illness, medication effects, or serious disease; learn causes, symptoms, and when to seek medical care.

Hormones impact almost all of our bodily functions, from skin, to the gut, to our moods. Here, experts on hormonal and metabolic health explain how to stay well

Leon co-founder believes the chain is struggling because it has drifted from its original mission of providing good quality fast-food

Donald Trump says a “very, very rich” friend of his is “fatter than ever” because weight loss drug Ozempic “doesn’t work on him.”

We see the before-and-after photos everywhere. The transformation is always celebrated—the dropped sizes, the defined jawlines, the newfound confidence. But look closer. Look at the texture of the skin around the mouth, the hollows under the eyes, and the crepey quality of the neck. There is a new phenomenon sweeping…

Some brokers say monthly outgoings on drugs such as Wegovy and Mounjaro can knock thousands off the amount you can borrow

One in eight U.S adults have used GLP-1s for weight loss or chronic conditions, according to a recent survey